Cargando…
Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
OBJECTIVE: Endoscopic remission is the primary therapeutic target and associated with clinical outcome in Crohn’s disease (CD). Non-invasive and accurate biomarkers are important in monitoring endoscopic remission frequently. Our study aimed at investigating the predictive capacity of prealbumin and...
Autores principales: | Chen, Rirong, Li, Li, Li, Chao, Su, Yuhan, Zhang, Yingfan, Pang, Xiaobai, Zheng, Jieqi, Zeng, Zhirong, Chen, Min-Hu, Zhang, Shenghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715867/ https://www.ncbi.nlm.nih.gov/pubmed/34992423 http://dx.doi.org/10.2147/JIR.S343125 |
Ejemplares similares
-
Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023) -
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021) -
Development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of Crohn’s disease
por: Zhou, Gaoshi, et al.
Publicado: (2022) -
Neutrophil-to-lymphocyte ratio for predicting postoperative
recurrence in Crohn’s disease patients with isolated anastomotic
lesions
por: Chen, Rirong, et al.
Publicado: (2023) -
Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
por: Chen, Rirong, et al.
Publicado: (2022)